EUVIMEDEUVIMED entdecken
Crossref

Synergy detection: A practical guide to statistical assessment of potential drug combinations

Elli Makariadou, Xuechen Wang iD, Nicholas Hein, Negera W Deresa, Kathy Mutambanengwe, Bie Verbist, Olivier Thas

Pharmaceutical Statistics · 2025

DOI: 10.1002/pst.2383 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Statistics, 2025. Verfasst von Elli Makariadou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Translational Medicine & Early Development Statistics, Janssen Research & Development, LLC, Beerse, Belgium. Hauptthemen laut MEDLINE: Drug Synergism, Models, Statistical, Drug Discovery. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Combination treatments have been of increasing importance in drug development across therapeutic areas to improve treatment response, minimize the development of resistance, and/or minimize adverse events. Pre‐clinical in‐vitro combination experiments aim to explore the potential of such drug combinations during drug discovery by comparing the observed effect of the combination with the expected treatment effect under the assumption of no interaction (i.e., null model). This tutorial will address important design aspects of such experiments to allow proper statistical evaluation. Additionally, it will highlight the Biochemically Intuitive Generalized Loewe methodology (BIGL R package available on CRAN) to statistically detect deviations from the expectation under different null models. A clear advantage of the methodology is the quantification of the effect sizes, together with confidence interval while controlling the directional false coverage rate. Finally, a case study will showcase the workflow in analyzing combination experiments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug SynergismModels, StatisticalDrug DiscoveryHumansDrug CombinationsResearch DesignData Interpretation, Statistical

Stichwörter der Autor:innen

BIGLdrug combinationsynergy

Substanzen

Drug Combinations

Autor:innen und Institutionen

  • Translational Medicine & Early Development Statistics, Janssen Research & Development, LLC, Beerse, Belgium.
  • Translational Medicine & Early Development Statistics, Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Data Science Institute, I-Biostat, Hasselt University, Hasselt, Belgium.
  • Statistical Consulting, Open Analytics, Antwerpen, Belgium.
  • National Institute for Applied Statistics Research Australia, University of Wollongong, Wollongong, New South Wales, Australia.
  • Department of Applied Mathematics, Computer Science and Statistics, Ghent University, Ghent, Belgium.

ORCID-Profile: Xuechen Wang

Zitieren

APA

Makariadou, E., Wang, X., Hein, N., Deresa, N. W., Mutambanengwe, K., Verbist, B., & Thas, O. (2025). Synergy detection: A practical guide to statistical assessment of potential drug combinations. Pharmaceutical Statistics. https://doi.org/10.1002/pst.2383

Vancouver

Makariadou E, Wang X, Hein N, Deresa NW, Mutambanengwe K, Verbist B, et al. Synergy detection: A practical guide to statistical assessment of potential drug combinations. Pharmaceutical Statistics. 2025. doi:10.1002/pst.2383

BibTeX
@article{Makariadou2025,
  author = {Makariadou, Elli and Wang, Xuechen and Hein, Nicholas and Deresa, Negera W and Mutambanengwe, Kathy and Verbist, Bie and Thas, Olivier},
  title = {Synergy detection: A practical guide to statistical assessment of potential drug combinations},
  journal = {Pharmaceutical Statistics},
  year = {2025},
  doi = {10.1002/pst.2383}
}
Kostenlos starten →